title: Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation.
abstract: Although opioids are known to affect neurogenesis in vivo, it is uncertain the extent to which opioids directly or indirectly affect the proliferation, differentiation or death of neuronal precursors. To address these questions, the intrinsic role of the opioid system in neurogenesis was systematically explored in cerebellar external granular layer (EGL) neuronal precursors isolated from postnatal mice and maintained in vitro. Isolated neuronal precursors expressed proenkephalin-derived peptides, as well as specific mu and delta, but negligible kappa, opioid receptors. The developmental effects of opioids were highly selective. Morphine-induced mu receptor activation inhibited DNA synthesis, while a preferential delta2-receptor agonist ([D-Ala2]-deltorphin II) or Met-enkephalin, but not the delta1 agonist [D-Pen2, D-Pen5]-enkephalin, inhibited differentiation within the same neuronal population. If similar patterns occur in the developing cerebellum, spatiotemporal differences in endogenous mu and delta opioid ligand-receptor interactions may coordinate distinct aspects of granule neuron maturation. The data additionally suggest that perinatal exposure to opiate drugs of abuse directly interfere with cerebellar maturation by disrupting normal opioid signalling and inhibiting the proliferation of granule neuron precursors.
authors.affiliation: Department of Anatomy & Neurobiology, University of Kentucky College of Medicine, Lexington, KY 40536-0298, USA. khauser@pop.uky.edu
authors.forename: K F
authors.initials: KF
authors.lastname: Hauser
authors.forename: A A
authors.initials: AA
authors.lastname: Houdi
authors.forename: C S
authors.initials: CS
authors.lastname: Turbek
authors.forename: R P
authors.initials: RP
authors.lastname: Elde
authors.forename: W
authors.initials: W
authors.lastname: Maxson
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000378:metabolism / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D001973:Bromodeoxyuridine / Q000378:metabolism / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D002531:Cerebellum / Q000737:chemistry / Q000166:cytology*; D004247:DNA / Q000096:biosynthesis; D020881:Enkephalin, D-Penicillamine (2,5)- / Q000494:pharmacology; D004744:Enkephalin, Methionine / Q000494:pharmacology; D004745:Enkephalins / Q000032:analysis; D066298:In Vitro Techniques; D051379:Mice; D008854:Microscopy, Electron; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D016501:Neurites / Q000502:physiology* / Q000648:ultrastructure; D009474:Neurons / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure*; D009842:Oligopeptides / Q000494:pharmacology; D009293:Opioid-Related Disorders / Q000378:metabolism; D011498:Protein Precursors / Q000032:analysis; D017465:Receptors, Opioid, delta / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D013234:Stem Cells / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure*
chemical_list: D000701:Analgesics, Opioid; D000963:Antimetabolites; D004745:Enkephalins; D009292:Narcotic Antagonists; D009842:Oligopeptides; D011498:Protein Precursors; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; C029992:proenkephalin; C060209:deltorphin II, Ala(2)-; D009270:Naloxone; D004744:Enkephalin, Methionine; D009020:Morphine; D020881:Enkephalin, D-Penicillamine (2,5)-; D004247:DNA; D001973:Bromodeoxyuridine